Attitudes of academic and clinical researchers toward financial ties in research: A systematic review

Science and Engineering Ethics

Volumn 11, Issue 4, 2005, Pages 553-573

  Glaser, Bonnie E ^a,b   Bero, Lisa A ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Conflicts of Interest; Faculty Surveys; Financial Disclosure; Research Support; University Industry Relationships

Indexed keywords

EID: 28344440947     PISSN: 13533452     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11948-005-0026-z     Document Type: Review

References (63)

1. Blumenthal, D., Gluck, M., Louis, K.S., Stoto, M.A., & Wise, D. (1986) University-industry research relationships in biotechnology: implications for the university. Science 232(4756): 1361-1366.
2. Blumenthal, D. (1994) Growing pains for new academic/industry relationships. Health Affairs 13(3): 176-193.
3. Louis, K.S., Anderson, M.S., & Rosenberg, L. (1995) Academic misconduct and values - the departments influence. Review of Higher Education 18(4): 393-422.
4. Blumenthal, D., Campbell, E.G., Causino, N., & Louis, K.S. (1996) Participation of life-science faculty in research relationships with industry. New England Journal of Medicine 335(23): 1734-1739.
5. Blumenthal, D. (2003) Academic-industrial relationships in the life sciences. New England Journal of Medicine 349(25): 2452-2459.
6. Krimsky, S. (2003) Science in the Private Interest: Has the Lure of Profits Corrupted Biomedical Research? Rowman & Littlefield Publishers, Lanham.
7. Bok, D.C. (2003) Universities in the Marketplace: the Commercialization of Higher Education. Princeton University Press, Princeton, N.J.
8. Boyd, E.A., & Bero, L.A. (2000) Assessing faculty financial relationships with industry: a case study. JAMA: Journal of the American Medical Association 284(17): 2209-2214.
9. Krimsky, S., Rothenberg, L.S., Stott, P., & Kyle, G. (1998) Scientific journals and their authors' financial interests: a pilot study. Psychotherapy and Psychosomatics 67(4-5): 194-201.
10. Krimsky, S., Ennis, J.G., & Weissman, R. (1991) Academic-corporate ties in biotechnology: a quantitative study. Science, Technology, and Human Values 16(3): 275-287.
11. Campbell, E.G., Louis, K.S., & Blumenthal, D. (1998) Looking a gift horse in the mouth: corporate gifts supporting life sciences research. JAMA: Journal of the American Medical Association 279(13): 995-999.
12. Cohen, J.J. (2001) Trust us to make a difference: ensuring public confidence in the integrity of clinical research. Academic Medicine 76(2): 209-214.
13. Bekelman, J.E., Li, Y., & Gross, C.P. (2003) Scope and impact of financial conflicts of interest in biomedical research: a systematic review. JAMA: Journal of the American Medical Association 289(4): 454-465.
14. Lexchin, J., Bero, L.A., Djulbegovic, B., & Clark, O. (2003) Pharmaceutical industry sponsorship and research outcome and quality: systematic review. British Medical Journal 326(7400): 1167-1170.
15. Bero, L.A., & Rennie, D. (1996) Influences on the quality of published drug studies. International Journal of Technology Assessment in Health Care 12(2): 209-237.
16. Boyd, E.A., Lipton, S., & Bero, L.A. (2004) Implementation of financial disclosure policies to manage conflicts of interest. Health Affairs 23(2): 206-214.
17. Boyd, E.A., Cho, M.K., & Bero, L.A. (2003) Financial conflict-of-interest policies in clinical research: issues for clinical investigators. Academic Medicine 78(8): 769-774.
18. Krimsky, S., Rothenberg, L.S., Stott, P., & Kyle, G. (1996) Financial interests of authors in scientific journals: a pilot study of 14 publications. Science and Engineering Ethics 2(4): 395-410.
19. Shamoo, A.E. (2003) Responsible Conduct of Research. Oxford University Press, Oxford, New York.
20. Campbell, P. (2001) Declaration of financial interests. Nature 412(6849): 751.
21. Van Kolfschooten, F. (2002) Conflicts of interest: can you believe what you read? Nature 416(6879), 360-363.
22. Duderstadt, J.J. (2000) A University For The 21st Century. University of Michigan Press, Ann Arbor.
23. Cho, M.K. (1998) Fundamental conflict of interest. The BioMedNet Magazine.
24. Alderson, P., Green, S., Higgins, J.P.T., & (eds). (2004) Cochrane Reviewers' Handbook 4.2.1. John Wiley &Sons, Ltd., Chichester, UK.
25. Bonnel, P., & Le Nir, M. (1998) The quality of survey data: telephone versus face-to-face interviews. Transportation 25(2): 147-167.
26. Decks, J.J., Dinnes, J., D'Amico, R., Sowden, A.J., Sakarovitch, C., Song, F., Petticrew, M., & Altman, D.G. (2003) Evaluating non-randomised intervention studies. Health Technology Assessment 7(27): iii-x, 1-173.
27. Downs, S.H., & Black, N. (1998) The feasibility of creating a checklist for the assessment of the methodological quality both of randomised and non-randomised studies of health care interventions. Journal of Epidemiology and Community Health 52(6): 377-384.
28. Grimes, D.A., & Schulz, K.F. (2002) Bias and causal associations in observational research. Lancet 359(9302): 248-252.
29. Hanscom, B., Lurie, J.D., Homa, K., & Weinstein, J.N. (2002) Computerized questionnaires and the quality of survey data. Spine 27(16): 1797-1801.
30. Mulrow, C., & Cook, D. eds. (1998) Systematic Reviews: Synthesis Of Best Evidence For Health Care Decisions. American College of Physicians, Philadelphia, Pa.
31. Sanchez, M.E. (1992) Effects of questionnaire design on the quality of survey data. Public Opinion Quarterly 56(2): 206-217.
32. Saris, W.E., Van Wijk, T., & Scherpenzeel, A. (1998) Validity and reliability of subjective social indicators - the effect of different measures of association. Social Indicators Research 45(1-3): 173-199.
33. Stroup, D.F., Berlin, J.A., Morton, S.C., Olkin, I., Williamson, G.D., Rennie, D., Moher, D., Becker, B.J., Sipe, T.A., & Thacker, S.B. (2000) Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group. JAMA: Journal of the American Medical Association 283(15): 2008-2012.
34. Zaza, S., Wright-De Aguero, L.K., Briss, P.A., Truman, B.I., Hopkins, D.P., Hennessy, M.H., Sosin, D.M., Anderson, L., Carande-Kulis, V.G., Teutsch, S.M., & Pappaioanou, M. (2000) Data collection instrument and procedure for systematic reviews in the Guide to Community Preventive Services. Task Force on Community Preventive Services. American Journal of Preventive Medicine 18(1 Suppl): 44-74.
35. Cho, M.K., & Bero, L.A. (1994) Instruments for assessing the quality of drug studies published in the medical literature. JAMA: Journal of the American Medical Association 272(2): 101-104.
36. Korenman, S.G., Berk, R., Wenger, N.S., & Lew, V. (1998) Evaluation of the research norms of scientists and administrators responsible for academic research integrity. JAMA: Journal of the American Medical Association 279(1): 41-47.
37. Lipton, S., Boyd, E.A., & Bero, L.A. (2004) Conflicts of interest in academic research: policies, processes, and attitudes. Accountability in Research 11(2): 83-102.
38. Executive Committee of College of Natural Resources. (1999) Faculty survey on the strategic alliance of the College of Natural Resources (CNR) with Novartis. Berkeley, CA: University of California.
39. Lee, Y.S. (1996) Technology transfer' and the research university: a search for the boundaries of university-industry collaboration. Research Policy 25(6): 843-863.
40. La Puma, J., Stocking, C.B., Rhoades, W.D., Darling, C.M., Ferner, R.E., Neuberger, J., VandenBurg, M., Dews, I., & Tobias, J.S. (1995) Financial ties as part of informed consent to postmarketing research. Attitudes of American doctors and patients. British Medical Journal 310(6995): 1660-1663.
41. Rabino, I. (1998) Societal and commercial issues affecting the future of biotechnology in the United States: a survey of researchers' perceptions. Naturwissenschaften 85(3): 109-116.
42. U.S. Congress Office of Technology Assessment. (1995) Federal Technology Transfer and the Human Genome Project (Report No. OTA-BP-EHR-162). Washington, DC: U.S. Government Printing Office.
43. Shelley, M.C., Woodman, W.F., Reichel, B.J., & Lasley, P. (1988) On the role of universities and biotechnology in economic development and public policy. Policy Studies Journal 17(1): 156-168.
44. Harman, G. (1999) Australian science and technology academics and university-industry research links. Higher Education 38(1): 83-103.
45. Rahm, D. (1994) Academic perceptions of university-firm technology transfer. Policy Studies Journal 22(2): 267-278.
46. Van Dierdonck, R., Debackere, K., & Engelen, B. (1990) University industry relationships - how does the Belgian academic community feel about it? Research Policy 19(6): 551-566.
47. Goldstein, D.J., & Wilson, M.G. (1996) Perceived conflicts of interest in clinical research: industry and academia. Drug Information Journal 30: 425-432.
48. Bebeau, M.J., & Davis, E.L. (1996) Survey of ethical issues in dental research. Journal of Dental Research 75(2): 845-855.
49. Brody, B.A., Anderson, C., McCrary, S.V., McCullough, L., Morgan, R., & Wray, N. (2003) Expanding disclosure of conflicts of interest: the views of stakeholders. IRB 25(1): 1-8.
50. Campbell, T.I.D., & Slaughter, S. (1995) Protecting The Public's Trust: A Search For Balance Among Benefits And Conflicts In University-Industry Relationships: Final Technical Report: Science and Technology Policy Initiative, Center for the Study of Higher Education, The University of Arizona.
51. Taylor, K.M. (1991) The Impact of the Pharmaceutical Industry's Clinical Research Programs on Medical Education, Practice, and Researchers in Canada: A Discussion Paper. In: Canadian Pharmaceutical Research and Development: Four Short-Term Studies. Ottawa: Department of Industry, Science and Technology.
52. Campbell, T.I.D., & Slaughter, S. (1999) Faculty and administrators' attitudes toward potential conflicts of interest, commitment, and equity in university-industry relationships. Journal of Higher Education 70(3): 309-+.
53. Dana, J., & Loewenstein, G. (2003) A social science perspective on gifts to physicians from industry. JAMA: Journal of the American Medical Association 290(2): 252-255.
54. Krimsky, S., & Rothenberg, L.S. (2001) Conflict of interest policies in science and medical journals: editorial practices and author disclosures. Science and Engineering Ethics 7(2): 205-218.
55. Chaudhry, S., Schroter, S., Smith, R., & Morris, J. (2002) Does declaration of competing interests affect readers' perceptions? A randomised trial. British Medical Journal 325(7377): 1391-1392.
56. Sackett, D. (2002) A survey of the credibility of identical trial results when generated by independent investigators or by drug manufacturers. Paper presented at the Symposium on "Data Monitoring Committees: Composition & Independence," at the 2002 Annual Meeting of the Society for Clinical Trials, Alexandria, Virginia, USA.
57. Schroter, S., Morris, J., Chaudhry, S., Smith, R., & Barratt, H. (2004) Does the type of competing interest statement affect readers' perceptions of the credibility of research? Randomised trial. British Medical Journal 328(7442): 742-743.
58. Lexchin, J. (1993) Interactions between physicians and the pharmaceutical industry: what does the literature say? Canadian Medical Association Journal 149(10), 1401-1407.
59. Cho, M.K., & Bero, L.A. (1996) The quality of drug studies published in symposium proceedings. Annals of Internal Medicine 124(5): 485-489.
60. Barnes, D.E., & Bero, L.A. (1998) Why review articles on the health effects of passive smoking reach different conclusions. JAMA: Journal of the American Medical Association 279(19): 1566-1570.
61. Steinbrook, R. (2005) Standards of ethics at the National Institutes of Health. New England Journal of Medicine 352(13): 1290-1292.
62. Willman, D. (2005, April 21) The Nation; Scientists add clout in NIH fight; Agency researchers who oppose conflict rules hire lawyers who also serve the drug industry. Los Angeles Times.
63. Schafer, A. (2004) Biomedical conflicts of interest: a defense of the sequestration thesis - learning from the cases of Nancy Olivieri and David Healy. JAMA: Journal of Medical Ethics 30(1): 8-24.